ÂÜÀòÂÒÂ×

Ken Rando currently serves as the Director of Cell Therapy at PHC Corporation of North America, a position held since November 2024. Prior to this role, Ken was the Sales Manager for Pharma / Cell & Gene Therapy at Comecer from August 2020 to November 2024, where responsibility included expanding the sector in North America using industry-leading equipment solutions. From December 2009 to July 2020, Ken held the title of Global Director of Business Development at BioSpherix Medical, overseeing global accounts focused on preclinical and clinical applications in the CGT field. Ken's career began at NEWPATH LEARNING, LLC, as a Marketing Manager from 2000 to 2009. Ken Rando earned a Bachelor of Science degree in Biomedical/Medical Engineering from the Rochester Institute of Technology between 1995 and 1999.